Accessibility StatementSkip Navigation SAN DIEGO, Nov. 3, 2025 /PRNewswire/ -- Robbins LLPÂ informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Dexcom, Inc. (NASDAQ: DXCM) securities between July 26, 2024 and September 17, 2025. DexCom is a medical device company primarily focused on the design, development, and commercialization of continuous glucose monitoring ("CGM") systems for the management of diabetes and metabolic health. The Company's pr ...